Page last updated: 2024-10-31

ethylmaleimide and Acquired Metabolic Diseases, Brain

ethylmaleimide has been researched along with Acquired Metabolic Diseases, Brain in 1 studies

Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Leandro, J1
Khamrui, S1
Suebsuwong, C1
Chen, PJ1
Secor, C1
Dodatko, T1
Yu, C1
Sanchez, R1
DeVita, RJ1
Houten, SM1
Lazarus, MB1

Other Studies

1 other study available for ethylmaleimide and Acquired Metabolic Diseases, Brain

ArticleYear
Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.
    Open biology, 2022, Volume: 12, Issue:9

    Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic; Cysteine; Ethylmaleimide;

2022